From: Stereotactic body radiotherapy (SBRT) in patients with lung metastases - prognostic factors and long-term survival using patient self-reported outcome (PRO)
Proportion surviving after
1-year
2-year
3-year
4-year
5-year
10-year
OS
74%
54%
39%
29%
26%
17%
DP
58%
46%
40%
37%
34%
32%
LC
92%
84%
78%
77%
75%